Last Updated: June 11, 2026

POLYETHYLENE Drug Patent Profile

Name: POLYETHYLENE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Polyethylene, and when can generic versions of Polyethylene launch?

Polyethylene is a drug marketed by Allied, Ani Pharms, Annora Pharma, Aurobindo Pharma Ltd, Breckenridge Pharm, Mylan, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharms Inc, Paddock Llc, Ppi-dac, Shree Hari Intl, Strides Pharma, Strides Pharma Intl, and Teva Pharms. and is included in eighteen NDAs.

The generic ingredient in POLYETHYLENE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for POLYETHYLENE?
What are the global sales for POLYETHYLENE?
What is Average Wholesale Price for POLYETHYLENE?

Summary for POLYETHYLENE

US Patents:	0
Applicants:	15
NDAs:	18
Drug Prices:	Drug price information for POLYETHYLENE
DailyMed Link:	POLYETHYLENE at DailyMed

Drug patent expirations by year for POLYETHYLENE

US Patents and Regulatory Information for POLYETHYLENE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allied	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	090812-001	Oct 7, 2009		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ppi-dac	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	090685-002	Oct 6, 2009		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Paddock Llc	POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous	FOR SOLUTION;ORAL	090712-001	Feb 25, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Ltd	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	209017-002	Apr 23, 2024		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for POLYETHYLENE

Is polyethylene glycol for constipation?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.